Did Kevin Hern buy Dexcom stock?

Common questions

Did Kevin Hern buy Dexcom stock?

Yes. Kevin Hern disclosed 1 purchase and 1 sale of Dexcom (DXCM) stock between Jul 1, 2021 and Dec 31, 2024, in STOCK Act reports. Added together, the disclosed purchases come to $100K-$250K and the disclosed sales to $50K-$100K.

How big were Kevin Hern's Dexcom trades?

STOCK Act reports give a range for each trade, such as $50K-$100K, never an exact amount. Added together, the disclosed purchases come to $100K-$250K and the disclosed sales to $50K-$100K.

Did Kevin Hern make these Dexcom trades personally?

Not always. The STOCK Act requires members to report trades by themselves, a spouse and dependent children. The owner column of each linked filing says whose trade it was.

Does Kevin Hern still own Dexcom stock?

This page lists reported trades, not holdings. A purchase can have been sold since, and the filings shown do not say what is held today.

When did Kevin Hern report these trades?

The latest filing is dated Jan 15, 2025. The STOCK Act gives members of Congress 45 days to report a trade, so a filing can trail the trade by weeks. Every row shows both dates.

Where does this data come from?

From periodic transaction reports filed under the STOCK Act with the Clerk of the House. Every trade links to the original filing.